Last edition
News about "Yusuke Fukujin"
CellProthera and Alfresa Sign MOU to Advance ProtheraCytes Phase 3 in Japan
CellProthera and Alfresa Holdings have signed a Memorandum of Understanding (MOU) to advance ProtheraCytes phase 3 development and future wholesale distribution in Japan for severe myocardial infarction.
Yusuke Fukujin | 13/08/2026 | By News Bureau
Ember LifeSciences and Alfresa Partner to Strengthen Japan's Pharma Cold Chain
Ember LifeSciences and Alfresa have formed a capital and business alliance to enhance Japan's pharmaceutical cold chain with advanced transport and traceability.
Yusuke Fukujin | 30/07/2026 | By News Bureau | 134
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy